June 5, 2024: Kigali, Rwanda and San Francisco, USA

Bio Usawa Inc. (BUI) is excited to welcome Raj Shankar Ghosh as Chief Innovation and Strategy Officer to its leadership team. With over three and a half decades of experience in program policy, planning and implementation of infectious disease solutions in India, Southeast Asia and Western Pacific regions, Raj Shankar brings rich experience of delivering drugs and vaccines to the last mile in a wide range of health systems settings.

Dr. Raj Shankar Ghosh is a physician with deep experience in policy, planning and delivery of public health programs. His primary work interests are in climate health, primary health care, infectious diseases, and vaccine delivery. In his career spanning more than three decades, Raj Shankar has worked in State Health Services in India as a Medical Officer at a Primary Health Centre, as Regional Coordinator in the National Polio Surveillance Project of the World Health Organization, as Vice President and Regional Coordinator, South Asia, Institute for OneWorld Health, as Director, Japanese Encephalitis Project for South Asian and Western Pacific Region at PATH and as Deputy Director, Vaccines and Infectious Diseases at the India office of Bill & Melinda Gates Foundation. Dr. Ghosh currently provides strategic and technical advice to national and international organizations on One Health, Climate Health, Disease Surveillance, and Immunization. Dr Ghosh is a recipient of an honorary Fellowship from the Indian Public Health Association for his contribution to public health in the South Asian region.

Dr Menghis Bairu, Co-founder and CEO of BUI, remarked, “Our journey towards healthcare equity in Africa is greatly augmented with the addition of Dr. Ghosh to our Executive team. His deep experience in international public health strategic and tactical leadership across governmental agencies and diverse initiatives make him an invaluable addition to our team. His vision aligns perfectly with our mission to revolutionize healthcare access across Africa.”

“I am delighted to join Bio Usawa and its efforts to bring high quality and affordable public health solutions to Africa and other countries in need,” Raj Shakar commented. “The medicines that BUI develops in collaboration with local African partners will be truly successful when they are made available and accessible to all, including particularly vulnerable populations. I am happy to work with the BUI team and our partners to develop and deliver lifesaving medicines, while building capacity and integrating our efforts across prevailing health systems in the African countries where we work. I look forward to the day when medicines developed at the BUI facilities are rolled out in African nations and patients have been treated with those medicines. For me, the benchmark of our success will be how soon we can ensure that every human life in African nations has access to the world class - and affordable - medicines that Bio Usawa manufactures."

The Bio Usawa team extends a warm welcome to Raj Shankar Ghosh, as we look forward to building a healthier future for Africa and beyond.